Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinli Han

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Gene|February 17, 2024
Integrated transcriptomic analysis systematically reveals the heterogeneity and molecular characterization of cancer-associated fibroblasts in osteosarcomaYuyang Liu, Xinli Han, Yuchen Han, et al.
Materials Today. Bio|June 12, 2023
Combination of IDO inhibitors and platinum(IV) prodrugs reverses low immune responses to enhance cancer chemotherapy and immunotherapy for osteosarcomaDongquan Xiang, Xinli Han, Jianxiong Li, et al.
Experimental Cell Research|September 9, 2021
PPARα agonist exerts protective effects in podocyte injury via inhibition of the ANGPTL3 pathwayXinli Han, Qianying Lv, Haimei Liu, et al.
Journal of Translational Medicine|June 24, 2026
Urinary ANGPTL3: a novel noninvasive biomarker for podocyte injury in pediatric glomerular diseasesHengmin Wang, Jiaojiao Liu, Rufeng Dai, et al.
Frontiers in Pediatrics|June 2, 2023
Angiopoietin-like protein 3: a novel potential biomarker for nephrotic syndrome in childrenFujie Wen, Junchao Liu, Rufeng Dai, et al.
Pediatric Nephrology (Berlin, Germany)|August 3, 2024
Protein-losing enteropathy as a new phenotype in atypical hemolytic uremic syndrome caused by CD46 gene mutationChunyan Wang, Jing Chen, Xinli Han, et al.
Advanced Healthcare Materials|December 3, 2025
Co-Delivery of Cisplatin and Curcumin via ROS-Responsive Nanoparticles to Activate the cGAS-STING Pathway for Osteosarcoma MetalloimmunotherapyYanan Wu, Yuchen Han, Wenchao Li, et al.
Cell Death & Disease|October 13, 2022
Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial damageQianying Lv, Xinli Han, Jiajia Ni, et al.
Renal Failure|November 14, 2024
Noninvasive genetic testing for type IV collagen nephropathy using oral mucosa DNA sampling in children with haematuriaJiaojiao Liu, Dayin Zhou, Xiaowen Wang, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Gene|February 17, 2024
Integrated transcriptomic analysis systematically reveals the heterogeneity and molecular characterization of cancer-associated fibroblasts in osteosarcomaYuyang Liu, Xinli Han, Yuchen Han, et al.
Materials Today. Bio|June 12, 2023
Combination of IDO inhibitors and platinum(IV) prodrugs reverses low immune responses to enhance cancer chemotherapy and immunotherapy for osteosarcomaDongquan Xiang, Xinli Han, Jianxiong Li, et al.
Experimental Cell Research|September 9, 2021
PPARα agonist exerts protective effects in podocyte injury via inhibition of the ANGPTL3 pathwayXinli Han, Qianying Lv, Haimei Liu, et al.
Journal of Translational Medicine|June 24, 2026
Urinary ANGPTL3: a novel noninvasive biomarker for podocyte injury in pediatric glomerular diseasesHengmin Wang, Jiaojiao Liu, Rufeng Dai, et al.
Frontiers in Pediatrics|June 2, 2023
Angiopoietin-like protein 3: a novel potential biomarker for nephrotic syndrome in childrenFujie Wen, Junchao Liu, Rufeng Dai, et al.
Pediatric Nephrology (Berlin, Germany)|August 3, 2024
Protein-losing enteropathy as a new phenotype in atypical hemolytic uremic syndrome caused by CD46 gene mutationChunyan Wang, Jing Chen, Xinli Han, et al.
Advanced Healthcare Materials|December 3, 2025
Co-Delivery of Cisplatin and Curcumin via ROS-Responsive Nanoparticles to Activate the cGAS-STING Pathway for Osteosarcoma MetalloimmunotherapyYanan Wu, Yuchen Han, Wenchao Li, et al.
Cell Death & Disease|October 13, 2022
Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial damageQianying Lv, Xinli Han, Jiajia Ni, et al.
Renal Failure|November 14, 2024
Noninvasive genetic testing for type IV collagen nephropathy using oral mucosa DNA sampling in children with haematuriaJiaojiao Liu, Dayin Zhou, Xiaowen Wang, et al.
Pageof 2